IVS logo - links back to home page

Faculty Biographies

Daniel A. Salmon Lawrence H. Moulton Neal A Halsey Kawsar R Talaat Matthew Z. Dudley Janesse Brewer
 

Daniel A. Salmon, PhD, Director

Daniel A Salmon 
Daniel A. Salmon, PhD, Director of the Institute for Vaccine Safety, has training, research and practice interests in epidemiology and health policy. He has focused on post-licensure vaccine safety and the factors associated with parental decisions to vaccinate or not vaccinate their children. Dr. Salmon served as the Director of Vaccine Safety at the National Vaccine Program Office, where he was responsible for overseeing and coordinating federal vaccine safety activities.

Dr. Salmon has conducted a broad range of studies examining the safety of vaccines, the rates of vaccine refusal, the reasons why parents refuse vaccines, the impact of health care providers and local and state policies on vaccine refusal and the individual and community risks of unvaccinated children. Dr. Salmon is widely published in the medical literature. Dr. Salmon is a professor in the Department of International Health where he also coordinates the PhD program in Global Disease Epidemiology and Control.

updated Apr 2020
 

Lawrence H. Moulton, PhD, Co-Director of Biostatistics

Lawrence H. Moulton
Lawrence H. Moulton, PhD, Co-Director of Biostatistics, is a biostatistician who focuses on issues of vaccine safety and effectiveness. He has made applied and theoretical contributions to the design and analysis of Phase II, III, and IV vaccine investigations. Dr. Moulton's areas of expertise include statistical epidemiology and cluster randomized trials.

He has served as a consultant to the FDA, CDC, PAHO, and WHO on issues of vaccine evaluation, and has received substantial National Institutes of Health funding for statistical research on vaccine evaluation. He has been the principal statistician on many large vaccine, HIV, and nutritional intervention trials. Dr. Moulton is a professor in the Department of International Health with a joint appointment in the Department of Biostatistics at the Johns Hopkins Bloomberg School of Public Health.

updated Oct 2018
 

Neal A. Halsey, MD, Director Emeritus

Neal A Halsey
Neal A. Halsey, MD, Director Emeritus of IVS, is an Emeritus Professor in the Department of International Health at the Johns Hopkins Bloomberg School of Public Health and in the Department of Pediatrics in the School of Medicine. Dr. Halsey served in the Epidemic Intelligence Service at the Centers for Disease Control and Prevention(CDC) in Atlanta. After 5 years as a faculty member at Tulane University he has been at Johns Hopkins University since 1985.

Dr. Halsey has authored more than 250 peer reviewed publications, 6 books, and 43 book chapters on the prevention and treatment of infectious diseases through vaccination, and he has participated in the development of more than 100 guidelines for the use of vaccines while serving on advisory groups for the WHO Expanded Programme on Immunization, the Advisory Committee for Immunization Practices (ACIP) for CDC, and the American Academy of Pediatrics Committee on Infectious Diseases.

Dr Halsey has focused his research and teaching in recent years on vaccine safety.

updated April 2020
 

Kawsar R. Talaat, MD, Co-Director of Clinical Research

Kawsar R Talaat
Kawsar R. Talaat, MD, IVS Co-Director of Clinical Research, is a physician who is board certified in Internal Medicine, Pediatrics and Infectious Diseases. She has extensive experience in the design and conduct of Phase 1 and 2 clinical vaccine trials for new vaccines, and in the conduct of challenge studies. She has served as the Principal Investigator for Phase 1 or 2 trials for a variety of vaccines, including influenza (pandemic and seasonal), malaria, Ebola, and bacteria that cause diarrhea including Enterotoxigenic E. coli (ETEC) and Shigella. In addition to her work on novel vaccines, Dr. Talaat is interested in the safety of existing vaccines. She is the Johns Hopkins Principal Investigator for the CDC Clinical Immunization Safety Assessment group; Dr. Talaat has served on several working groups looking at vaccine safety and has co-authored a WHO-sponsored systematic review of the safety of influenza vaccines in children. She is also a member of the WHO Strategic Advisory Group of Experts Influenza Working Group.

Dr. Talaat is an Assistant Professor in the Department of International Health at the Johns Hopkins Bloomberg School of Public Health and has a joint appointment in the Johns Hopkins School of Medicine.

updated Oct 2018
 

Matthew Z. Dudley, PhD, MSPH, Co-Director of Epidemiology

Matthew Z Dudley
Matthew Z. Dudley, PhD, MSPH, Co-Director of Epidemiology, is an Assistant Scientist in the Department of International Health at the Johns Hopkins Bloomberg School of Public Health. Dr. Dudley has coordinated several research studies exploring topics ranging from norovirus transmission in peri-urban settlements in Peru to multi-level interventions to increase vaccine confidence and informed decision making among obstetric patients.

Dr. Dudley published a book entitled, The Clinician’s Vaccine Safety Resource Guide: Optimizing Prevention of Vaccine-Preventable Diseases Across the Lifespan; he has published in academic journals on topics ranging from hospital infection control of drug resistant tuberculosis to vaccine safety, hesitancy and uptake. He has also served as a consultant for organizations such as the World Health Organization and the Coalition for Epidemic Preparedness Innovations.

updated May 2019
 

Janesse Brewer, MPA, IVS Co-director of Stakeholder and Community Engagement

Janesse Brewer, MPA, IVS Co-director of Stakeholder and Community Engagement is an Associate in the Department of International Health. Janesse works primarily in the areas of environment, public health, art, and education. She specializes in mediations and community engagement where science, data, cultural norms, trust, and values intersect. Janesse is a senior practitioner with more than 20 years of experience in mediation, facilitation, and stakeholder engagement.

Ms. Brewer has conducted strategic planning, policy dialogues, site-specific mediations, and public engagement processes at local, state, national and international levels. She has worked with ASTHO, NACCHO, HHS, CDC, health advocates and communities on the issue of vaccine safety and vaccinomics

updated Dec 2020
The information on this page was last updated on Dec 28, 2020 | © 2020 Institute for Vaccine Safety